On February 20, 2024, AIM ImmunoTech Inc. closed the transaction. The transaction included participation from a single investor. The company has paid sales commissions of $1,300,000?
in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 USD | +7.65% | +8.57% | -13.62% |
May. 16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
May. 15 | AIM ImmunoTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
On February 20, 2024, AIM ImmunoTech Inc. closed the transaction. The transaction included participation from a single investor. The company has paid sales commissions of $1,300,000?
in the transaction.
1st Jan change | Capi. | |
---|---|---|
-13.62% | 18.1M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |